annual accounts payable:
N/ASummary
- TGTX annual accounts payable is not available.
Performance
TGTX Accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
quarterly accounts payable:
N/ASummary
- TGTX quarterly accounts payable is not available.
Performance
TGTX quarterly accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
Accounts payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
TGTX Accounts payable Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | - | - |
3 y3 years | - | - |
5 y5 years | - | - |
TGTX Accounts payable Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | ||||
5 y | 5-year | ||||
alltime | all time |
TGTX Accounts payable History
Date | Annual | Quarterly |
---|---|---|
Sep 2020 | - | $34.66M(+16.8%) |
Jun 2020 | - | $29.67M(-26.2%) |
Mar 2019 | - | $40.20M(+6.0%) |
Sep 2018 | - | $37.92M(+7.1%) |
Jun 2018 | - | $35.39M(+8.9%) |
Mar 2018 | - | $32.51M(+78.8%) |
Sep 2017 | - | $18.18M(-3.9%) |
Mar 2017 | - | $18.92M(+23.9%) |
Dec 2016 | $15.27M(+63.4%) | $15.27M(-1.8%) |
Sep 2016 | - | $15.55M(+18.9%) |
Jun 2016 | - | $13.08M(+60.7%) |
Mar 2016 | - | $8.14M(-12.9%) |
Dec 2015 | $9.35M(+134.1%) | $9.35M(+8.9%) |
Sep 2015 | - | $8.58M(+4.0%) |
Jun 2015 | - | $8.25M(-7.1%) |
Mar 2015 | - | $8.88M(+122.5%) |
Dec 2014 | $3.99M(-16.2%) | $3.99M(-49.9%) |
Sep 2014 | - | $7.97M(+319.5%) |
Jun 2014 | - | $1.90M(+15.9%) |
Mar 2014 | - | $1.64M(-65.6%) |
Dec 2013 | $4.76M(+326.4%) | $4.76M(+10.2%) |
Sep 2013 | - | $4.33M(+92.4%) |
Jun 2013 | - | $2.25M(+61.9%) |
Mar 2013 | - | $1.39M(+24.2%) |
Dec 2012 | $1.12M(+67.6%) | $1.12M(-37.9%) |
Sep 2012 | - | $1.80M(+459.3%) |
Jun 2012 | - | $321.70K(-31.2%) |
Mar 2012 | - | $467.50K(-29.9%) |
Dec 2011 | $666.60K(+198.3%) | $666.60K(+297.5%) |
Sep 2011 | - | $167.70K(-19.2%) |
Jun 2011 | - | $207.60K(+13.3%) |
Mar 2011 | - | $183.30K(-18.0%) |
Dec 2010 | $223.50K(-23.2%) | $223.50K(-43.5%) |
Sep 2010 | - | $395.80K(+5.9%) |
Jun 2010 | - | $373.80K(+23.5%) |
Mar 2010 | - | $302.70K(+3.9%) |
Dec 2009 | $291.20K | $291.20K(+103.5%) |
Sep 2009 | - | $143.10K(-17.2%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2009 | - | $172.90K(+19.7%) |
Mar 2009 | - | $144.50K(-73.4%) |
Dec 2008 | $542.30K(-57.6%) | $542.30K(-23.1%) |
Sep 2008 | - | $705.30K(+14.3%) |
Jun 2008 | - | $617.30K(-37.4%) |
Mar 2008 | - | $986.20K(-22.9%) |
Dec 2007 | $1.28M(-8.2%) | $1.28M(+50.1%) |
Sep 2007 | - | $852.50K(-14.9%) |
Jun 2007 | - | $1.00M(-34.3%) |
Mar 2007 | - | $1.52M(+9.4%) |
Dec 2006 | $1.39M(-13.9%) | $1.39M(+28.4%) |
Sep 2006 | - | $1.09M(-44.7%) |
Jun 2006 | - | $1.96M(-1.4%) |
Mar 2006 | - | $1.99M(+23.1%) |
Dec 2005 | $1.62M(+41.4%) | $1.62M(-5.6%) |
Sep 2005 | - | $1.71M(+31.5%) |
Jun 2005 | - | $1.30M(+17.2%) |
Mar 2005 | - | $1.11M(-2.8%) |
Dec 2004 | $1.14M(+108.5%) | $1.14M(-17.5%) |
Sep 2004 | - | $1.39M(+235.3%) |
Jun 2004 | - | $413.50K(-27.4%) |
Mar 2004 | - | $569.40K(+3.8%) |
Dec 2003 | $548.60K(+232.7%) | $548.60K(-27.9%) |
Sep 2003 | - | $760.50K(+32.5%) |
Jun 2003 | - | $574.00K(+21.2%) |
Mar 2003 | - | $473.70K(+187.3%) |
Dec 2002 | $164.90K(-67.6%) | $164.90K(-67.3%) |
Sep 2002 | - | $503.90K(+17.8%) |
Jun 2002 | - | $427.70K(-11.8%) |
Mar 2002 | - | $484.70K(-4.7%) |
Dec 2001 | $508.60K(-35.3%) | $508.60K(-32.0%) |
Sep 2001 | - | $748.40K(+5.9%) |
Jun 2001 | - | $706.90K(-9.3%) |
Mar 2001 | - | $779.20K(-0.8%) |
Dec 2000 | $785.80K(+57.2%) | $785.80K(-26.0%) |
Sep 2000 | - | $1.06M(+95.7%) |
Jun 2000 | - | $542.50K(+9.4%) |
Mar 2000 | - | $495.90K(-0.8%) |
Dec 1999 | $500.00K | $500.00K |
FAQ
- What is the all time high annual accounts payable for TG Therapeutics?
- What is the all time high quarterly accounts payable for TG Therapeutics?
What is the all time high annual accounts payable for TG Therapeutics?
TG Therapeutics all-time high annual accounts payable is $15.27M
What is the all time high quarterly accounts payable for TG Therapeutics?
TG Therapeutics all-time high quarterly accounts payable is $40.20M